Figure S5 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling Article Swipe
Dandan Li
,
Anne M. Miermont
,
Rushikesh Sable
,
Humair S. Quadri
,
Lesley A. Mathews Griner
,
Scott E. Martin
,
Taivan Odzorig
,
Soumita De
,
Marc Ferrer
,
Astin S. Powers
,
Stephen M. Hewitt
,
Udo Rudloff
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.22552180.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.22552180.v1
Selumetinib fails to recruit CNKSR1 and p-AKT to the plasma membrane in CNKSR1 low cell lines; Proximal ligation of CNKSR1 and p-AKT in CNKSR1 low cell lines treated with vehicle vs selumetinib;CNKSR1 p-AKT PLA signal after treatment with selumetinib is dependent on the presence of both primary antibodies; Silencing of CNKSR1 in the CNKSR1high cell lines abrogates PLA signal; and Immunofluorescence staining of PIP3 and CNKSR1 in YAPC treated with vehicle and selumetinib.
Related Topics
Concepts
Selumetinib
Protein kinase B
Cancer research
MAPK/ERK pathway
Cell biology
Chemistry
Signal transduction
MEK inhibitor
Molecular biology
Biology
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1541-7786.22552180.v1
- https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362543020
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362543020Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1541-7786.22552180.v1Digital Object Identifier
- Title
-
Figure S5 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT SignalingWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-04Full publication date if available
- Authors
-
Dandan Li, Anne M. Miermont, Rushikesh Sable, Humair S. Quadri, Lesley A. Mathews Griner, Scott E. Martin, Taivan Odzorig, Soumita De, Marc Ferrer, Astin S. Powers, Stephen M. Hewitt, Udo RudloffList of authors in order
- Landing page
-
https://doi.org/10.1158/1541-7786.22552180.v1Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdfDirect OA link when available
- Concepts
-
Selumetinib, Protein kinase B, Cancer research, MAPK/ERK pathway, Cell biology, Chemistry, Signal transduction, MEK inhibitor, Molecular biology, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362543020 |
|---|---|
| doi | https://doi.org/10.1158/1541-7786.22552180.v1 |
| ids.doi | https://doi.org/10.1158/1541-7786.22552180.v1 |
| ids.openalex | https://openalex.org/W4362543020 |
| fwci | 0.0 |
| type | preprint |
| title | Figure S5 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11533 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9473999738693237 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Melanoma and MAPK Pathways |
| topics[1].id | https://openalex.org/T13779 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9108999967575073 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Cancer Mechanisms and Therapy |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776087337 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9289698600769043 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7448840 |
| concepts[0].display_name | Selumetinib |
| concepts[1].id | https://openalex.org/C75217442 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7988805770874023 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q423650 |
| concepts[1].display_name | Protein kinase B |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5370264649391174 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C57074206 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5056076049804688 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q14197552 |
| concepts[3].display_name | MAPK/ERK pathway |
| concepts[4].id | https://openalex.org/C95444343 |
| concepts[4].level | 1 |
| concepts[4].score | 0.45523858070373535 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[4].display_name | Cell biology |
| concepts[5].id | https://openalex.org/C185592680 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4530588388442993 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[5].display_name | Chemistry |
| concepts[6].id | https://openalex.org/C62478195 |
| concepts[6].level | 2 |
| concepts[6].score | 0.37171754240989685 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q828130 |
| concepts[6].display_name | Signal transduction |
| concepts[7].id | https://openalex.org/C2781249067 |
| concepts[7].level | 4 |
| concepts[7].score | 0.36748749017715454 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q17142288 |
| concepts[7].display_name | MEK inhibitor |
| concepts[8].id | https://openalex.org/C153911025 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3218913972377777 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[8].display_name | Molecular biology |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3143935203552246 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/selumetinib |
| keywords[0].score | 0.9289698600769043 |
| keywords[0].display_name | Selumetinib |
| keywords[1].id | https://openalex.org/keywords/protein-kinase-b |
| keywords[1].score | 0.7988805770874023 |
| keywords[1].display_name | Protein kinase B |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5370264649391174 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/mapk/erk-pathway |
| keywords[3].score | 0.5056076049804688 |
| keywords[3].display_name | MAPK/ERK pathway |
| keywords[4].id | https://openalex.org/keywords/cell-biology |
| keywords[4].score | 0.45523858070373535 |
| keywords[4].display_name | Cell biology |
| keywords[5].id | https://openalex.org/keywords/chemistry |
| keywords[5].score | 0.4530588388442993 |
| keywords[5].display_name | Chemistry |
| keywords[6].id | https://openalex.org/keywords/signal-transduction |
| keywords[6].score | 0.37171754240989685 |
| keywords[6].display_name | Signal transduction |
| keywords[7].id | https://openalex.org/keywords/mek-inhibitor |
| keywords[7].score | 0.36748749017715454 |
| keywords[7].display_name | MEK inhibitor |
| keywords[8].id | https://openalex.org/keywords/molecular-biology |
| keywords[8].score | 0.3218913972377777 |
| keywords[8].display_name | Molecular biology |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.3143935203552246 |
| keywords[9].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1158/1541-7786.22552180.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1541-7786.22552180.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22552180 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5038447699 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9139-3118 |
| authorships[0].author.display_name | Dandan Li |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Dandan Li |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5050665929 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8366-5304 |
| authorships[1].author.display_name | Anne M. Miermont |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Anne M. Miermont |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5091392055 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6128-2190 |
| authorships[2].author.display_name | Rushikesh Sable |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Rushikesh Sable |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5019493678 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1708-5269 |
| authorships[3].author.display_name | Humair S. Quadri |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Humair S. Quadri |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5021784750 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9847-1107 |
| authorships[4].author.display_name | Lesley A. Mathews Griner |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Lesley A. Mathews Griner |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5063029120 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5685-9787 |
| authorships[5].author.display_name | Scott E. Martin |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Scott E. Martin |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5004702663 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0877-2692 |
| authorships[6].author.display_name | Taivan Odzorig |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Taivan Odzorig |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5021905605 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-3247-0317 |
| authorships[7].author.display_name | Soumita De |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Soumita De |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5002699549 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4569-9137 |
| authorships[8].author.display_name | Marc Ferrer |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Marc Ferrer |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5082550776 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6514-2670 |
| authorships[9].author.display_name | Astin S. Powers |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Astin S. Powers |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5011055578 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8283-1788 |
| authorships[10].author.display_name | Stephen M. Hewitt |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Stephen M. Hewitt |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5028439777 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-2137-9040 |
| authorships[11].author.display_name | Udo Rudloff |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Udo Rudloff |
| authorships[11].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Figure S5 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11533 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9473999738693237 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Melanoma and MAPK Pathways |
| related_works | https://openalex.org/W2085971843, https://openalex.org/W3031789451, https://openalex.org/W2103749352, https://openalex.org/W2505698301, https://openalex.org/W2890752806, https://openalex.org/W2906115228, https://openalex.org/W2125095478, https://openalex.org/W2080686146, https://openalex.org/W4361824042, https://openalex.org/W2865458437 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1541-7786.22552180.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1541-7786.22552180.v1 |
| primary_location.id | doi:10.1158/1541-7786.22552180.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Scaffolding_Protein_Connector_Enhancer_of_Kinase_Suppressor_of_Ras_1_CNKSR1_Regulates_MAPK_Inhibition_Responsiveness_in_Pancreas_Cancer_via_Crosstalk_with_AKT_Signaling/22552180/1/files/40019596.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1541-7786.22552180.v1 |
| publication_date | 2023-04-04 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 11, 22, 51, 66 |
| abstract_inverted_index.is | 39 |
| abstract_inverted_index.of | 18, 44, 49, 62 |
| abstract_inverted_index.on | 41 |
| abstract_inverted_index.to | 2, 7 |
| abstract_inverted_index.vs | 30 |
| abstract_inverted_index.PLA | 33, 57 |
| abstract_inverted_index.and | 5, 20, 59, 64, 71 |
| abstract_inverted_index.low | 13, 24 |
| abstract_inverted_index.the | 8, 42, 52 |
| abstract_inverted_index.PIP3 | 63 |
| abstract_inverted_index.YAPC | 67 |
| abstract_inverted_index.both | 45 |
| abstract_inverted_index.cell | 14, 25, 54 |
| abstract_inverted_index.with | 28, 37, 69 |
| abstract_inverted_index.after | 35 |
| abstract_inverted_index.fails | 1 |
| abstract_inverted_index.lines | 26, 55 |
| abstract_inverted_index.p-AKT | 6, 21, 32 |
| abstract_inverted_index.CNKSR1 | 4, 12, 19, 23, 50, 65 |
| abstract_inverted_index.lines; | 15 |
| abstract_inverted_index.plasma | 9 |
| abstract_inverted_index.signal | 34 |
| abstract_inverted_index.primary | 46 |
| abstract_inverted_index.recruit | 3 |
| abstract_inverted_index.signal; | 58 |
| abstract_inverted_index.treated | 27, 68 |
| abstract_inverted_index.vehicle | 29, 70 |
| abstract_inverted_index.Proximal | 16 |
| abstract_inverted_index.ligation | 17 |
| abstract_inverted_index.membrane | 10 |
| abstract_inverted_index.presence | 43 |
| abstract_inverted_index.staining | 61 |
| abstract_inverted_index.Silencing | 48 |
| abstract_inverted_index.abrogates | 56 |
| abstract_inverted_index.dependent | 40 |
| abstract_inverted_index.treatment | 36 |
| abstract_inverted_index.CNKSR1high | 53 |
| abstract_inverted_index.antibodies; | 47 |
| abstract_inverted_index.selumetinib | 38 |
| abstract_inverted_index.Immunofluorescence | 60 |
| abstract_inverted_index.selumetinib;CNKSR1 | 31 |
| abstract_inverted_index.<p>Selumetinib | 0 |
| abstract_inverted_index.selumetinib.</p> | 72 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.19370452 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |